NervGen Pharma Corp. Common stock

NGEN | NASDAQ

Price Alert Chart Builder DCF Calculator

$1.37

-$0.07 (-4.86%)

At close: Oct 30, 2026, 4:00 PM ET

$1.48

+$0.11 (+8.03%)

Pre-market: Nov 2, 2026, 8:19 AM ET

Overview Rating Statistics Financials Earnings Analysts Ownership Profile

Income Statement Balance Sheet Cashflow Statement Ratios

Annual Quarterly TTM

Fiscal Year Period Ending	FY 2025 Dec 31, 2025	FY 2024 Dec 31, 2024	FY 2023 Dec 31, 2023	FY 2022 Dec 31, 2022	FY 2021 Dec 31, 2021	FY 2020 Dec 31, 2020
Net Income	-44.12M	-23.99M	-22.38M	-20.54M	-12.82M	-11.21M
Depreciation & Amortization	55.8K	83.74K	145.01K	114.1K	42.95K	39.73K
Stock-Based Compensation	5.39M	n/a	n/a	n/a	n/a	n/a
Other Working Capital	591.22K	1M	-17.17K	2.06M	435.19K	1.35M
Other Non-Cash Items	18.51M	6.24M	11.18M	701.82K	4.01M	3.44M
Deferred Income Tax	n/a	n/a	n/a	n/a	n/a	n/a
Change in Working Capital	657.46K	837.99K	-240.37K	2.1M	433.77K	1.41M
Operating Cash Flow	-19.5M	-16.83M	-11.3M	-17.63M	-8.33M	-6.32M
Capital Expenditures	n/a	n/a	-5.63K	-20.92K	-2.77K	-3.43K
Cash Acquisitions	n/a	n/a	2.55K	n/a	n/a	n/a
Purchase of Investments	n/a	n/a	n/a	n/a	n/a	n/a
Sales Maturities Of Investments	n/a	58.83K	n/a	n/a	n/a	n/a
Other Investing Acitivies	100.93K	n/a	n/a	n/a	n/a	n/a
Investing Cash Flow	100.93K	58.83K	-138.87K	-20.92K	-45.43K	-3.43K
Debt Repayment	-100.93K	n/a	n/a	n/a	n/a	n/a
Common Stock Repurchased	n/a	n/a	n/a	n/a	n/a	n/a
Dividend Paid	n/a	n/a	n/a	n/a	n/a	n/a
Other Financial Acitivies	-892.78K	-100.86K	-100.93K	-75.03K	n/a	n/a
Financial Cash Flow	23.76M	22.68M	766.35K	22.44M	19.76M	7.87M
Net Cash Flow	4.8M	4.6M	-10.29M	4.27M	11.46M	1.57M
Free Cash Flow	-19.5M	-16.83M	-11.3M	-17.65M	-8.33M	-6.32M
Adj. Free Cash Flow	-24.89M	-16.83M	-11.3M	-17.65M	-8.33M	-6.32M
Maintenance CapEx	n/a	n/a	-5.63K	-20.92K	-2.77K	-3.43K
Growth CapEx	n/a	n/a	n/a	n/a	n/a	n/a
Owner Earnings	-19.5M	-16.83M	-11.3M	-17.65M	-8.33M	-6.32M